These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8497659)

  • 1. Retardation and arrest of progression or regression of coronary artery disease: a review.
    Vos J; de Feyter PJ; Simoons ML; Tijssen JG; Deckers JW
    Prog Cardiovasc Dis; 1993; 35(6):435-54. PubMed ID: 8497659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular pharmacology (XII). Pharmacologic interventions in the progression of coronary atherosclerosis].
    Rayo Llerena I; Marín Huerta E
    Rev Esp Cardiol; 1995 May; 48(5):341-58. PubMed ID: 7792429
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium channel blockers and progression of coronary artery disease.
    Henry PD
    Circulation; 1990 Dec; 82(6):2251-3. PubMed ID: 2242548
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is regression of coronary sclerosis possible?].
    Krayenbühl HP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1348-53. PubMed ID: 8272700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression and regression of the atherosclerotic plaque.
    de Feyter PJ; Vos J; Deckers JW
    Eur Heart J; 1995 Aug; 16 Suppl I():26-30. PubMed ID: 8829954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is regression of human atherosclerosis a clinical reality?
    Simons LA
    Med J Aust; 1994 May; 160(9):531-2. PubMed ID: 8164548
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium antagonists and atherosclerosis].
    Pohjola-Sintonen S; Heikkilä J
    Duodecim; 1991; 107(17):1420-3. PubMed ID: 1365370
    [No Abstract]   [Full Text] [Related]  

  • 8. Can we cause regression of coronary atherosclerosis?
    Alsafwah S; Ramanathan KB
    Am J Med Sci; 2008 May; 335(5):368-74. PubMed ID: 18480653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs that delay the progression of coronary atherosclerosis.
    Ferraro-Borgida M; Waters D
    Cardiologia; 1997 Feb; 42(2):149-61. PubMed ID: 9090160
    [No Abstract]   [Full Text] [Related]  

  • 10. [Can drugs, especially calcium antagonists, bring about regression of atherosclerosis, especially coronary sclerosis?].
    Lichtlen PR
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1807-12. PubMed ID: 1754861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid factors and evolution of the atherosclerotic plaque: review of recent trials].
    Scardi S
    G Ital Cardiol; 1996 Dec; 26(12):1481-93. PubMed ID: 9162677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.
    Jost S; Rafflenbeul W; Deckers J; Wiese B; Hecker H; Nikutta P; Lippolt P; Lichtlen P
    Eur J Epidemiol; 1992 May; 8 Suppl 1():107-19. PubMed ID: 1505647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study].
    Castaigne A; Albo C; Pham I; Saal JP; Verschuren P
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering to delay the progression of coronary artery disease.
    Feher MD
    Heart; 2003 Apr; 89(4):451-8. PubMed ID: 12639883
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of calcium antagonists and atherosclerosis.
    Keogh AM; Schroeder JS
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S28-35. PubMed ID: 1707112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists and development of the atheromatous plaque].
    Weber S
    Arch Mal Coeur Vaiss; 1997 May; 90 Spec No 2():51-3. PubMed ID: 9295927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regression of coronary arteriosclerosis by treatment of disorders of lipid metabolism? Initial clinical results and methodologic problems].
    von Essen R
    Internist (Berl); 1992 Jan; 33(1):62-6. PubMed ID: 1551764
    [No Abstract]   [Full Text] [Related]  

  • 18. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
    Bergstrand L
    Acta Radiol Suppl; 1994; 392():1-27. PubMed ID: 8184697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
    Mancini GB; Miller ME; Evans GW; Byington R; Furberg CD; Pitt B;
    Am J Cardiol; 2002 Jun; 89(12):1414-6. PubMed ID: 12062738
    [No Abstract]   [Full Text] [Related]  

  • 20. [The significance of improvement of the lipid profile on progression and regression of the coronary atherosclerosis--a quantitative analysis using coronary angiography].
    Iwase T; Nakanishi S; Nishiyama S; Seki A
    Jpn Circ J; 1994; 58 Suppl 4():1297-300. PubMed ID: 7699779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.